Medical
Biotechnology
Pharmaceutical
Progenics Pharmaceuticals
$5.249876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.24
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.02 (-0.32%) As of 12:51 PM EDT today
-$0.02 (-0.32%) Today
Why Robinhood?
You can buy or sell PGNX and other stocks, options, ETFs, and crypto commission-free!
About PGNX
Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. Read More The company was founded by Paul J. Maddon in 1986 and is headquartered in New York, NY.
Employees
79
Headquarters
New York, New York
Founded
1986
Market Cap
444.69M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
691.94K
High Today
$5.34
Low Today
$5.17
Open Price
$5.32
Volume
258.48K
52 Week High
$9.42
52 Week Low
$3.62
Collections
Medical
Biotechnology
Pharmaceutical
Cancer Prevention
Therapy
Health
Technology
Price Paid on Robinhood
7% Lower
Right Now
52 Week Low
$3.62
Average Price Paid
$5.61
52 Week High
$9.42
PGNX Earnings
-$0.23
-$0.16
-$0.08
-$0.01
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Jul 30, Pre-Market